1RSX - Header Asymmetric Unit

HEADER METAL BINDING PROTEIN 10-DEC-03 1RSX

TITLE 12-MER FROM SITE II CALBINDIN D9K (DKNGDGEVSFEE) TITLE 2 COORDINATING CD(II)

COMPND MOL_ID: 1; COMPND 2 MOLECULE: VITAMIN D-DEPENDENT CALCIUM-BINDING PROTEIN, COMPND 3 INTESTINAL; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: RESIDUES 57-68 (SWS P02632); COMPND 6 SYNONYM: CABP, CALBINDIN D9K; COMPND 7 ENGINEERED: YES

SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: OCCURS NATURALY IN MAMMALS CALCIUM BINDING SOURCE 4 PROTEIN AS THE SECOND CALCIUM BINDING SITE. PURCHASED TO SOURCE 5 COMMONWEALTH BIOTECHNOLOGIES, INC. AS THE TRIFLUOROACETATE SOURCE 6 SALT, PUR. MIN 95%

KEYWDS EF-HAND TOXIC METAL ION TRANSPORT MODEL OF ICABP KEYWDS 2 COORDINATION TOWARD CADMIUM, METAL BINDING PROTEIN

EXPDTA SOLUTION NMR

NUMMDL 10

AUTHOR R.FERRARI,G.MENDOZA,T.JAMES,M.TONELLI,V.BASUS,L.GASQUE

REVDAT 2 24-FEB-09 1RSX 1 VERSN REVDAT 1 26-JUL-05 1RSX 0

JRNL AUTH R.FERRARI,G.MENDOZA,T.JAMES,M.TONELLI,V.BASUS, JRNL AUTH 2 L.GASQUE JRNL TITL COORDINATION COMPOUNDS DERIVED FROM A JRNL TITL 2 DODECAPEPTIDE AND PB2+, CD2+ AND ZN2+. MODELING JRNL TITL 3 THE SITE II FROM THE CALBINDIN D9K JRNL REF TO BE PUBLISHED JRNL REFN

REMARK 1

REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : DYANA 1.5 REMARK 3 AUTHORS : GUENTER, MUMENTHALER, HERRMANN REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL

REMARK 4 REMARK 4 1RSX COMPLIES WITH FORMAT V. 3.15, 01-DEC-08

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-JAN-04. REMARK 100 THE RCSB ID CODE IS RCSB021019.

REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 288 REMARK 210 PH : 6.6 REMARK 210 IONIC STRENGTH : APROX 0 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 3MM PEPTIDE AND CD(NO3)2. REMARK 210 NAOH AND HNO3 ADDED FOR PH REMARK 210 FIXING TO 6.6; 80% H2O, 20% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D TOCSY, NOESYJR REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : UNITY REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE 1.0, MARDIGRAS 3.2, REMARK 210 DYANA 1.5 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 20 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL

REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS.

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ASN A 3 -39.41 -175.06 REMARK 500 1 GLU A 7 160.34 -44.07 REMARK 500 1 SER A 9 76.81 -61.62 REMARK 500 1 PHE A 10 13.09 59.97 REMARK 500 2 ASN A 3 -54.60 158.60 REMARK 500 2 ASP A 5 32.60 -147.39 REMARK 500 2 GLU A 7 149.79 -33.77 REMARK 500 2 VAL A 8 48.45 30.97 REMARK 500 2 SER A 9 74.71 -64.34 REMARK 500 3 ASN A 3 33.92 39.46 REMARK 500 3 ASP A 5 16.55 87.40 REMARK 500 3 GLU A 7 159.00 -38.46 REMARK 500 3 VAL A 8 64.32 -65.33 REMARK 500 3 SER A 9 74.56 -62.65 REMARK 500 3 PHE A 10 15.02 56.31 REMARK 500 4 ASN A 3 -84.37 -167.59 REMARK 500 4 ASP A 5 179.78 81.80 REMARK 500 4 VAL A 8 -149.46 32.71 REMARK 500 4 SER A 9 68.10 62.45 REMARK 500 4 PHE A 10 20.85 49.04 REMARK 500 5 LYS A 2 54.07 -98.81 REMARK 500 5 ASN A 3 -35.73 167.96 REMARK 500 5 ASP A 5 -153.17 -124.35 REMARK 500 5 GLU A 7 -177.37 -55.05 REMARK 500 5 VAL A 8 47.37 35.00 REMARK 500 6 LYS A 2 62.01 28.67 REMARK 500 6 ASN A 3 -83.76 -164.22 REMARK 500 6 GLU A 7 134.05 -22.98 REMARK 500 6 VAL A 8 51.17 32.28 REMARK 500 6 PHE A 10 14.98 56.24 REMARK 500 6 GLU A 11 -169.87 -125.33 REMARK 500 7 ASN A 3 14.46 93.92 REMARK 500 7 ASP A 5 -157.90 -63.99 REMARK 500 7 GLU A 7 41.39 -85.49 REMARK 500 7 VAL A 8 32.33 -145.83 REMARK 500 7 GLU A 11 -169.99 -58.92 REMARK 500 8 ASN A 3 -37.61 173.42 REMARK 500 8 ASP A 5 -176.33 155.87 REMARK 500 8 GLU A 7 172.60 51.06 REMARK 500 8 VAL A 8 36.49 35.10 REMARK 500 8 GLU A 11 -168.10 -66.82 REMARK 500 9 ASN A 3 -67.26 -158.51 REMARK 500 9 ASP A 5 30.92 39.35 REMARK 500 9 VAL A 8 51.19 31.17 REMARK 500 9 GLU A 11 -171.54 -53.42 REMARK 500 10 LYS A 2 52.05 -97.42 REMARK 500 10 ASN A 3 -69.41 -179.25 REMARK 500 10 VAL A 8 30.80 37.73 REMARK 500 10 GLU A 11 -172.92 -50.71 REMARK 500 REMARK 500 REMARK: NULL

REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1RSW RELATED DB: PDB REMARK 900 THE SAME PEPTIDE COMPLEXED WITH PB(II)

DBREF 1RSX A 1 12 UNP P02632 S100G_PIG 57 68

SEQRES 1 A 12 ASP LYS ASN GLY ASP GLY GLU VAL SER PHE GLU GLU

CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 1.000000 0.000000 0.000000 0.00000

SCALE2 0.000000 1.000000 0.000000 0.00000

SCALE3 0.000000 0.000000 1.000000 0.00000